world Pancreatic Cancer Day, observed annually on November 20, brings critical focus to a disease with a persistently low survival rate.Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2030, according to the National cancer Institute. This article examines the challenges of diagnosing and treating this aggressive cancer, with insights from oncologist Daniel Öhlund, MD, PhD, at Umeå University in Sweden, who details the disease’s progression, symptoms, and ongoing research efforts.
World Pancreatic Cancer Day is observed annually on November 20, raising awareness of this challenging disease and fundraising for research aimed at improving survival rates. Pancreatic cancer remains a particularly difficult cancer to treat, and understanding the disease is crucial for early detection and improved outcomes.
But what exactly is pancreatic cancer, and why is it so often diagnosed at a late stage? Daniel Öhlund, MD, PhD, an oncologist at Umeå University in Sweden, explains the disease, its progression, and the symptoms to watch for.
What is Pancreatic Cancer and Why is Early Detection So Difficult?
Table of Contents
- What is Pancreatic Cancer and Why is Early Detection So Difficult?
- What are the Most Common Symptoms – and When Should You Seek Medical Attention?
- What Risk Factors Increase the Likelihood of Developing Pancreatic Cancer?
- What Progress Has Been Made in Research in Recent Years?
- What is the Research Landscape at Umeå University and What’s Currently in Progress?
Pancreatic cancer, also known as cancer of the pancreas, is a malignant tumor that develops in the pancreas – an organ located deep within the abdomen responsible for vital functions in digestion and blood sugar regulation. It’s often difficult to detect in its early stages because it frequently presents with few or nonspecific symptoms. The tumor can grow for a considerable period without causing noticeable issues, and by the time symptoms appear, the disease has often spread. This contributes to a poorer prognosis for patients with pancreatic cancer compared to many other types of cancer.
What are the Most Common Symptoms – and When Should You Seek Medical Attention?
Symptoms of pancreatic cancer can be subtle and include:
– Jaundice (yellowing of the skin and whites of the eyes)
– Unexplained weight loss
– Abdominal or back pain
– Loss of appetite and fatigue
– New-onset diabetes in adults
Early diagnosis is key to improving outcomes, so it’s important to consult a doctor if you experience any of these symptoms, especially if they are persistent or worsening.
<div class="content">
<h2 class="factsheader">Understanding Pancreatic Cancer</h2>Pancreatic cancer most often originates in the small ducts of the pancreas where pancreatic juice flows.
Approximately 1,500 people are diagnosed with pancreatic cancer each year in Sweden. Three-quarters of those diagnosed are over the age of 65.
The five-year survival rate for individuals diagnosed with pancreatic cancer is estimated to be 8.6 percent for women and 6.2 percent for men.
Source: Cancerfonden
What Risk Factors Increase the Likelihood of Developing Pancreatic Cancer?
Several factors can increase the risk of developing pancreatic cancer:
– Smoking (one of the strongest risk factors)
– Advanced age
– Chronic pancreatitis (inflammation of the pancreas)
– Genetic factors (such as mutations in the BRCA genes or a family history of pancreatic cancer)
What Progress Has Been Made in Research in Recent Years?
Over the past decade, research interest in pancreatic cancer has grown, leading to improvements in surgical techniques and chemotherapy combinations that have increased survival for some patients. The development of new blood and tissue biomarkers for earlier disease detection is also underway. Recent years have also seen the emergence of new targeted therapies, which are expected to be introduced into clinical practice in the coming years and may further improve prognosis, particularly for patients with advanced disease.
What is the Research Landscape at Umeå University and What’s Currently in Progress?
Research at Umeå University focuses on several key areas, including:
– The tumor’s supporting tissue, particularly cancer-associated fibroblasts (cells that produce the extensive tumor connective tissue found in pancreatic tumors) and how they affect cancer cells and the immune system.
– Biomarkers in blood to predict treatment response and prognosis.
– New treatment strategies, such as modulating the tumor’s supporting tissue to make it more receptive to therapy.
– New methods for endoscopically diagnosing and treating pancreatic cancer (examination or treatment from inside the body using a camera-equipped instrument inserted through the mouth).
– Clinical collaborations to connect laboratory findings with patient data and improve treatment precision.
Umeå University is currently conducting numerous clinical trials, enrolling patients to test new treatment methods and to donate blood and tissue samples to facilitate research into new biomarkers.
